{'fraction_non_alphanumeric': 0.03197674418604651, 'fraction_numerical': 0.023255813953488372, 'mean_word_length': 5.076470588235294, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Intrapartum Amnioinfusion in Meconium-stained Amniotic fluid: A Case Control study

Objective- The Aim of this study is to investigate Perinatal outcome and the rate of ceserean section following intrapartam amnioinfusion in women with Meconium Stained Amniotic Fluid (MASF). Method- A total of 100 women at term in labour with meconium stained amniotic fluid were randomised to receive either Transcervical Intrapartum Amnioinfusion with normal saline (50) or routine obstetric care (50). Perinatal outcome and obstetric outcome were recorded and analysed in both groups. Result- The ceserean section rate due to fetal distress was 34% in the control group and 10% in the study group. Respiratory distress of the neonate was significantly less common in the study group than in the control group (p=0.0053). The rate of Meconium Aspiration Syndrome (MAS) was 20% in the control group and 4% in the study study group.(p=0.0433). Conclusion- Amniotransfusion in cases of MSAF significantly improved neonatal outcome and decreases the